Sino Biopharmaceutical Limited (SBHMY)
OTCMKTS · Delayed Price · Currency is USD
15.89
0.00 (0.00%)
At close: Feb 2, 2026
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of $15.62 billion as of February 11, 2026. Its market cap has increased by 129.81% in one year.
Market Cap
15.62B
Enterprise Value
16.25B
Revenue
4.27B
Ranking
n/a
PE Ratio
28.90
Stock Price
$15.89
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 42.32M to 15.62B, an increase of 36,805.93%. That is a compound annual growth rate of 26.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 15.62B | 10.03% |
| Dec 31, 2025 | 14.19B | 89.25% |
| Dec 31, 2024 | 7.50B | -8.23% |
| Dec 29, 2023 | 8.17B | -24.55% |
| Dec 30, 2022 | 10.83B | -17.52% |
| Dec 31, 2021 | 13.13B | -27.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |